Lund, June 9, Hamlet Pharma soon to be Hamlet BioPharma, the innovative pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, invites to investor presentation at Aktiespararnas Capital Market Day on June 12 in Stockholm.
The founder and Chairman Catharina Svanborg will present at 13.30 CET on June 12 at Birger Jarlsgatan 61 A.
Sign up here to participate in Stockholm:
Watch the presentation here:
More information about the event is available on:
Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections, an additional pharmaceutical project with patent rights for the treatment of tuberculosis is acquired.
A warm welcome!